P3 Health Partners SPAC Presentation Deck slide image

P3 Health Partners SPAC Presentation Deck

Pro Forma Capitalization and Ownership Estimated Transaction Sources And Uses¹ ($mm) Sources ($mm) Existing P3 equity rollover SPAC cash in trust Private placement of common equity Total sources Uses ($mm) Existing P3 equity rollover Cash proceeds to selling shareholders Cash to balance sheet from transaction Est. transaction fees and expenses Total uses $1,811 316³ 209 $2,336 $1,811 315 180 30 4 $2,336 1 Transaction expenses are an estimate; 2 Total pro forma shares outstanding assumes 181.1mm from existing P3 shareholders, 31.6mm from Foresight shareholders, 20.9mm from new PIPE investors and 8.7mm from Foresight sponsor. Excludes outstanding public warrants and warrants held by SPAC sponsor and any shares that may be issued in connection with a warrant exchange offer or solicitation of approval to amend the warrants; 3 Assumes no redemptions; 4 May be reduced to the extent SPAC cash in trust is reduced prior to closing by public stockholder redemptions; 5 As of 04/30/21; 6 Includes $180mm of cash to balance sheet from transaction and $14mm from cash on balance sheet of P3 as of 04/30/21 Note: Any lock-up of Company equity holder shares shall be mutually determined by the Company and Foresight in advance of signing of Definitive Agreements (it being understood that such lock-up may be limited to shares issued to executive officers, directors and parties that currently own five percent or more of the outstanding equity interests of the Company) and shall not exceed 180 days; Cash and debt are shown as of 04/30/21 and may fluctuate prior to, and may be more or less at Closing Post-money Valuation At Close ($mm)² PF transaction Illustrative P3 share price PF shares outstanding Total PF equity value (+) debt at close (-) cash at close Total PF enterprise value 2022E revenue 2023E revenue PF 2022E EV / revenue PF 2023E EV / revenue Illustrative Post Transaction Ownership² PIPE shareholders 8.6% Foresight shareholders 13.0% Foresight sponsor 3.6% O Existing P3 shareholders 74.7% $10.00 242.3 $2,423 61 5 (194) $2,290 $825 $1,255 6 2.8x 1.8x 319 P3
View entire presentation